Altimmune, Inc. announced that Richard Eisenstadt, the company?s chief financial officer passed away on June 24, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.68 USD | +2.67% |
|
+16.01% | -31.73% |
Jul. 01 | Altimmune, Inc.(NasdaqGM:ALT) added to Russell 3000 Growth Index | CI |
Jul. 01 | Altimmune, Inc.(NasdaqGM:ALT) added to Russell Microcap Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.73% | 530M | |
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |
- Stock Market
- Equities
- ALT Stock
- News Altimmune, Inc.
- Altimmune, Inc. Announces Demise of Richard Eisenstadt, Chief Financial Officer